Jones Financial Companies
IART icon

Jones Financial Companies’s Integra LifeSciences IART Stock Holding History

Jones Financial Companies’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.2K Buy
224
+65
+41% +$909 ﹤0.01% 4177
2026
Q1 		$1.46K Sell
159
-2,886
-95% -$31.7K ﹤0.01% 4243
2025
Q4 		$37.8K Sell
3,045
-134
-4% -$1.78K ﹤0.01% 2658
2025
Q3 		$42K Sell
3,179
-262
-8% -$3.59K ﹤0.01% 2455
2025
Q2 		$42.3K Buy
3,441
+137
+4% +$1.99K ﹤0.01% 2285
2025
Q1 		$71.7K Sell
3,304
-41
-1% -$964 ﹤0.01% 1916
2024
Q4 		$75.9K Buy
3,345
+32
+1% +$698 ﹤0.01% 1725
2024
Q3 		$59.2K Buy
+3,313
New +$76.8K ﹤0.01% 1579
2021
Q2 		– Sell
-24
Closed -$2K – 709
2021
Q1 		$2K Buy
+24
New +$1.63K ﹤0.01% 736

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Jones Financial Companies's IART Position: Q2 2026 in Review

Jones Financial Companies increased its Integra LifeSciences (IART) stake by 41% in Q2 2026, buying an estimated $909 and bringing the position to 224 shares worth $4.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4177.

Jones Financial Companies first reported a position in IART in Q1 2021 and has held it in 9 quarters since. The position peaked at $75.9K in Q4 2024. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Jones Financial Companies held 224 shares of Integra LifeSciences worth $4.2K as of Q2 2026.
  • Jones Financial Companies bought 65 Integra LifeSciences shares in Q2 2026, an estimated $909.
  • Integra LifeSciences made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4177 holding.
  • Jones Financial Companies first reported a position in Integra LifeSciences in Q1 2021 and has held it in 9 quarters since.
  • Jones Financial Companies's Integra LifeSciences position peaked at $75.9K in Q4 2024.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.